About this test
Detects BRAF V600 mutations, which guide BRAF/MEK inhibitor therapy in melanoma and inform prognosis and treatment in colorectal and thyroid cancer.
- Clinical area
- Molecular oncology
- Method
- PCR
- Sample
- FFPE tissue block
- Report languages
- EN · AR · RU
When to order
Advanced melanoma, metastatic colorectal cancer, or suspicious thyroid nodules.
Results are reported to the ordering physician and should be interpreted in clinical context.
Request this test
Offer this test to your patients.
Contract pricing and turnaround times are provided on request for laboratories and clinics.
Molecular oncology